 - Patients with history of other non-urothelial malignancies may enroll if: 1no evidence of distant disease win last year. 2No anticancer treatment for 1 year other than adjuvant treatment or treatment for secondary prevention. 3 Less than 360 mgm2 lifetime dose of adriamycin. 